— Know what they know.
Not Investment Advice

ORGS OTC

Orgenesis Inc.
1W: +16.0% 1M: +65.7% 3M: +45.0% YTD: +286.7% 1Y: -26.6% 3Y: -90.7% 5Y: -98.8%
$0.58
+0.03 (+5.45%)
 
Weekly Expected Move ±739.3%
$-8 $-4 $1 $5 $9
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 67 · $5.7M mcap · 7M float · 0.0071% daily turnover · Short 76% of daily vol

Balance Sheet Trends

Total Assets
$15M -84.0% ▼
5Y CAGR: -28.0%
Total Liabilities
$36M +12.3% ▲
5Y CAGR: -5.4%
Shareholders Equity
-$21M -176.1% ▼
Cash & Investments
$837K -84.2% ▼
5Y CAGR: -44.6%
Total Debt
$23M +11.6% ▲
5Y CAGR: +43.4%
Net Debt
$22M +45.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$11M$45M$5M$5M$837K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$11M$45M$5M$5M$837K
Net Receivables$2M$3M$20M$40M$3M
Inventory$2M$185K$118K$120K$34K
Other Current Assets$10M$645K-$687K$1M$642K
Total Current Assets$26M$50M$26M$46M$4M
Property, Plant & Equip.$34M$5M$11M$25M$2M
Goodwill & Intangibles$29M$22M$20M$18M$9M
Long-Term Investments$3M$175K$152K$135K$8K
Other Non-Current Assets$3M$821K$805K$1M$56K
Total Non-Current Assets$67M$28M$34M$45M$10M
Total Assets$92M$78M$60M$91M$15M
— Liabilities —
Accounts Payable$6M$9M$5M$4M$7M
Short-Term Debt$807K$4M$6M$5M$3M
Deferred Revenue$11M$751K$1M$2M$0
Other Current Liabilities$10M$1M$2M$2M$3M
Total Current Liabilities$32M$16M$15M$16M$16M
Long-Term Debt$13M$7M$5M$13M$19M
Other Non-Current Liab.$0$387K$389K$434K$61K
Total Non-Current Liabilities$55M$9M$6M$16M$19M
Total Liabilities$86M$25M$21M$32M$36M
— Equity —
Common Stock$2K$3K$3K$3K$3K
Retained Earnings-$89M-$88M-$106M-$121M-$177M
Accumulated OCI$213K$748K$207K-$270K$65K
Total Stockholders Equity$5M$53M$38M$28M-$21M
Total Liabilities & Equity$92M$78M$60M$91M$15M
— Key Metrics —
Total Debt$25M$13M$12M$20M$23M
Net Debt$13M-$32M$6M$15M$22M
Total Investments$3M$175K$152K$135K$8K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms